Skip to content

Digital Mental Health Care for COVID-19 High-Risk Populations

Digital Mental Health Care for COVID-19 High-Risk Populations

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04964570
Enrollment
4134
Registered
2021-07-16
Start date
2021-08-04
Completion date
2021-12-25
Last updated
2022-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Help-Seeking Behavior, Stigma, Social

Brief summary

The mental health consequences of the COVID-19 pandemic are likely to be vast, exceeding the capacity of mental health services and delaying treatment for people in need, with devastating consequences for those affected. Emerging data suggest that frontline health workers (e.g. physicians, nurses, EMTs) and essential workers (in industries such as energy, and food products and services) face particular risks for mental health problems during and after the COVID-19 outbreak. To address the unprecedented mental health needs during and as a result of the COVID-19 pandemic this study will develop and test novel, cost-effective and scalable, digitally-delivered mental health interventions, and will test this approach by focusing on health care workers and other essential workers.

Detailed description

Stigma towards mental health care is a profound obstacle that interferes with individuals seeking these services. Research suggests that interventions that are based on social contact are the most efficient way to reduce stigma. By combining online video and interactive behavioral change modules, this study aims to address stigma and both empower essential workers (healthcare and non-healthcare workers) both to seek treatment for mental health issues as well as to reduce psychiatric symptoms by increasing social support, facilitating sleep hygiene, and maintaining physical exercise. A total of 4,200 members of these high-risk groups will be recruited to participate in a randomized controlled trial (RCT) testing the efficacy of the intervention. The intervention will consist of brief videos in which empowered members of the respective high-risk group (presented by actors) share their COVID-19 related mental health problems and describe how they were able to confront their mental health problems, which in turn helped them seek mental health care. The video will be followed by a short, interactive, digital behavioral change module. Within each high-risk group, individuals will first be randomized to receive the video (one time), video plus booster (second administration of the video), or non-intervention video control. The study will randomize participants within each high-risk group into one of three arms: 1\) Video + Behavioral Change Module, with Booster: 2-3-minute video (in which empowered members of the respective high-risk group (protagonists) share their COVID-19 related mental health problems and describe how they were able to confront their mental health problems, which in turn helped them seek mental health care) will be followed by 3-4-minute online digital behavioral change modules at days 1 and 14 of the study (video+booster); 2) Video + Behavioral change modules without Booster: 2-3-minute video will be followed by 3-4-minute online digital behavioral change modules at day 1 only (video); 3) No Intervention video (Control Arm): Participants randomized to this arm will receive video not related to mental health (control). Following the intervention, the study includes three follow-ups (day 14, 30, and 90) to examine longer-term effects.

Interventions

BEHAVIORALVideo _ behavioral change module

A short video (primary outcome) that aimed at reducing stigma towards treatments and increasing help seeking intentions. The behavioral change module (secondary outcome) is aimed at changing behaviors of sleep, exercise and social support.

Sponsors

Columbia University
CollaboratorOTHER
Research Foundation for Mental Hygiene, Inc.
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Intervention model description

Randomized Controled Trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Essential workers (including healthcare workers) * Age of 18-80 * US resident * English speaker

Exclusion criteria

* N/A

Design outcomes

Primary

MeasureTime frameDescription
Help Seeking Intentions (3 items of the ATSPPH)Immediately after the interventionChange in treatment seeking intentions from baseline - higher score, indicate higher help seeking intentions (range of 3 to 12)
Stigma (the SSOSH-3)immediately after the interventionChange in stigma items from baseline - higher score, indicate higher stigma (range of 3 to 12)
Stigma (3 items of the SSOSH-3)14 days after the interventionChange in stigma items from baseline - higher score, indicate higher stigma (range of 3 to 12)

Secondary

MeasureTime frameDescription
Behaviors questionnaire14 days after the interventionFour questions about sleep (quality of sleep), exercise (amount of weekly exercise) and social habits (weekly number of people one contacted). We will measure change from baseline
Clinical outcome - PTSD14 days after the interventionChange from baseline in PC-PTSD (range 0-5, higher than 2 indicates high probability of PTSD)
Clinical outcome - Anxiety14 days after the interventionChange from baseline in GAD-7 (range 0-21, higher score indicate more anxiety)
Clinical outcome - Depression14 days after the interventionChange from baseline in PHQ-9 (range 0-27, higher score indicate more depression)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026